<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>26(7)</volume><submitter>Nevala W</submitter><funding>Sorrento Therapeutics, Inc.</funding><journal>International journal of molecular sciences</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11989481</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>PD-L1-Targeting Nanoparticles for the Treatment of Triple-Negative Breast Cancer: A Preclinical Model</pubmed_title><pmcid>PMC11989481</pmcid><pubmed_authors>Xie H</pubmed_authors><pubmed_authors>Stueven N</pubmed_authors><pubmed_authors>Nevala W</pubmed_authors><pubmed_authors>Geng L</pubmed_authors><pubmed_authors>Markovic S</pubmed_authors></additional><is_claimable>false</is_claimable><name>PD-L1-Targeting Nanoparticles for the Treatment of Triple-Negative Breast Cancer: A Preclinical Model</name><description/><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Apr</publication><modification>2025-06-26T03:05:52.17Z</modification><creation>2025-06-26T03:05:52.17Z</creation></dates><accession>S-EPMC11989481</accession><cross_references/></HashMap>